tiprankstipranks
Percheron Therapeutics (AU:PER)
ASX:PER
Holding AU:PER?
Track your performance easily

Percheron Therapeutics (PER) Technical Analysis

11 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Percheron Therapeutics’s (PER) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Percheron Therapeutics is a Buy.
Percheron Therapeutics’s (PER) 20-Day exponential moving average is 0.08, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) 50-Day exponential moving average is 0.09, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.

Percheron Therapeutics (PER) Pivot Points

Nov 25, 2024, 10:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.07
0.08
0.08
0.08
0.08
Fibonacci
0.07
0.07
0.07
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Percheron Therapeutics (PER) Moving Averages

Nov 25, 2024, 10:11 AM
Period
Simple
Exponential
MA5
0.08Sell
0.08Sell
MA10
0.08Sell
0.08Sell
MA20
0.08Sell
0.08Sell
MA50
0.09Sell
0.09Sell
MA100
0.09Sell
0.09Sell
MA200
0.08Sell
0.08Sell
Percheron Therapeutics’s (PER) 10-Day exponential moving average is 0.08, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) 100-Day exponential moving average is 0.09, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 50-day simple moving average is 0.09, creating a Sell signal.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 100-day simple moving average is 0.09, creating a Sell signal.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 200-day simple moving average is 0.08, creating a Sell signal.

Percheron Therapeutics (PER) Technical Indicators

Nov 25, 2024, 10:11 AM
Name
Value
Implied Action
RSI (14)
34.90
Neutral
STOCH (9,6)
2.78
Buy
STOCHRSI (14)
2.78
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
21.48
Neutral
Williams %R
-100.00
Buy
CCI (14)
-174.34
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
22.65
Sell
ROC
-5.13
Sell
Percheron Therapeutics’s (PER) Relative Strength Index (RSI) is 34.90, creating a Neutral signal.
Percheron Therapeutics’s (PER) Trend Strength Indicator (ADX) is 21.48, creating a Neutral signal.
Percheron Therapeutics’s (PER) Commodity Channel Index (CCI) is -174.34, creating a Buy signal.
Percheron Therapeutics’s (PER) Price Rate of Change (ROC) is -5.13, creating a Sell signal.

FAQ

Is PER a Buy, Hold, or Sell?
Based on PER’s technical indicators, PER is a Sell.
    What is PER’s RSI (14)?
    PER’s RSI (14) is 34.90, which suggests PER is a Neutral.
      What is PER’s MACD?
      PER’s MACD is >-0.01, which suggests PER is a Buy.
        What is PER’s 5-day moving average?
        PER’s 5-day moving average is 0.08, which suggests PER is a Sell.
          What is PER’s 20-day moving average?
          PER 20-day moving average is 0.08, which suggests PER is a Sell.
            What is PER’s 50-day moving average?
            PER’s 50-day moving average is 0.09, which suggests PER is a Sell.
              What is PER’s 200-day moving average?
              PER’s 200-day moving average is 0.08, which suggests PER is a Sell.
                What is PER’s Williams % R (14)?
                PER’s Williams % R (14) is -100.00, which suggests PER is a Buy.
                  What is PER’s CCI (14)?
                  PER’s CCI (14) is -174.34, which suggests PER is a Buy.
                    What is the share price of Percheron Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis